Established in 1921, Cleveland Clinic is a global, multi-specialty academic medical system with roots in the United States, Canada and the Middle East. In 2006, Cleveland Clinic Canada opened a state of the art 26,000-square-foot outpatient clinic in the heart of the financial district in downtown Toronto. Since opening our doors we built a phenomenal team who share a passion for introducing our unique model of care--a model that leverages the expertise and clinical excellence of Cleveland Clinic in a way that complements healthcare in Canada.
Over the years, Cleveland Clinic has built a strong reputation for outstanding quality healthcare. U.S. News & World Report has consistently ranked Cleveland Clinic as one of America's top four hospitals and has recognized our Heart & Vascular Institute as No. 1 in America since 1994.
Many major medical breakthroughs have happened at Cleveland Clinic, including the first coronary artery bypass surgery, the first nearly full facial transplant and the first successful experimental artificial heart. Our physicians and researchers continue to make life-changing discoveries in many areas, including cancer, heart disease, Parkinson's disease and stroke.
Overview & Quick Facts
- Founded in 1921
- 5.1 million patient visits per year
- 3,000+ physicians & scientists
Cleveland Clinic's Key Innovations
- Isolation of serotonin, a key factor in hypertension (1940s)
- First coronary angiography (1958)
- Development and refinement of coronary bypass surgery (1967)
- First minimally invasive aortic heart valve surgery (1996)
- First successful larynx transplant (1998)
- Pioneering success in deep brain stimulation for psychiatric disorders (2006)
- First kidney surgery performed through a patient’s navel (2007)
- United States’ first near-total face transplant (2008)
- United States’ first transcatheter valve replacement and repair (2011)
- Discovery that adult brain neurons can regenerate (2011)
- Demonstration that bariatric surgery controls diabetes (2012)
- Discovery that an intestinal bacteria product (TMAO) can predict heart disease risk (2013)